These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31055190)

  • 1. A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study.
    Ferrari D; Bagaglio S; Raso M; Galli L; Premaschi S; Messina E; Morsica G; Locatelli M; Uberti-Foppa C; Hasson H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():1-7. PubMed ID: 31055190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
    Notari S; Tempestilli M; Fabbri G; Libertone R; Antinori A; Ammassari A; Agrati C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():183-190. PubMed ID: 29276983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
    Abdallah OM; Abdel-Megied AM; Gouda AS
    Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS.
    Shi X; Zhu D; Lou J; Zhu B; Hu AR; Gan D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():353-7. PubMed ID: 26363369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
    Pan C; Chen Y; Chen W; Zhou G; Jin L; Zheng Y; Lin W; Pan Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():255-259. PubMed ID: 26684720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development a validated highly sensitive LC-MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS-331007 in human plasma: Application to a human pharmacokinetic study.
    Abdallah OM; Abdel-Megied AM; Gouda AS
    J Pharm Biomed Anal; 2017 Sep; 143():305-310. PubMed ID: 28645021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid bioanalytical LC-MS/MS method for the simultaneous determination of sofosbuvir and velpatasvir in human plasma-application to a pharmacokinetic study in Egyptian volunteers.
    Elkady EF; Aboelwafa AA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():116-124. PubMed ID: 30384188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of second generation direct-acting antivirals daclatasvir, elbasvir, grazoprevir, ledipasvir, simeprevir, sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS.
    van Seyen M; de Graaff Teulen MJA; van Erp NP; Burger DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():15-24. PubMed ID: 30776611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated RP-HPLC Method for Simultaneous Determination of Ribavirin, Sofosbuvir and Daclatasvir in Human Plasma: A Treatment Protocol Administered to HCV Patients in Egypt.
    Youssef AA; Magdy N; Hussein LA; El-Kosasy AM
    J Chromatogr Sci; 2019 Aug; 57(7):636-643. PubMed ID: 31063182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.
    Rezk MR; Basalious EB; Karim IA
    J Pharm Biomed Anal; 2015 Oct; 114():97-104. PubMed ID: 26037157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma.
    Ariaudo A; Favata F; De Nicolò A; Simiele M; Paglietti L; Boglione L; Cardellino CS; Carcieri C; Di Perri G; D'Avolio A
    J Pharm Biomed Anal; 2016 Jun; 125():369-75. PubMed ID: 27131146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
    Chavez-Eng CM; Lutz RW; Li H; Goykhman D; Bateman KP; Woolf E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():204-14. PubMed ID: 26773885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel and sensitive UPLC-MS/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study.
    Rezk MR; Basalious EB; Amin ME
    Biomed Chromatogr; 2016 Sep; 30(9):1354-62. PubMed ID: 26821881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a method using supported liquid extraction for the simultaneous determination of midazolam and 1'-hydroxy-midazolam in human plasma by liquid chromatography with tandem mass spectrometry detection.
    Svanström C; Hansson GP; Svensson LD; Sennbro CJ
    J Pharm Biomed Anal; 2012 Jan; 58():71-7. PubMed ID: 21993197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rapid and Optimized LC-MS/MS Method for the Simultaneous Extraction and Determination of Sofosbuvir and Ledipasvir in Human Plasma.
    Elkady EF; Aboelwafa AA
    J AOAC Int; 2016 Sep; 99(5):1252-9. PubMed ID: 27480956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UPLC-MS/MS method for determination of sofosbuvir in human plasma.
    Gandhi BM; Rao AL; Rao JV
    Ann Pharm Fr; 2017 Jul; 75(4):257-266. PubMed ID: 28495020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of Vitamin A, 25-hydroxyl vitamin D
    Zhang H; Quan L; Pei P; Lin Y; Feng C; Guan H; Wang F; Zhang T; Wu J; Huo J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1079():1-8. PubMed ID: 29421441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of sofosbuvir and ledipasvir in human plasma by UPLC-MS/MS method: Application to fasting and fed bioequivalence studies.
    Rezk MR; Bendas ER; Basalious EB; Karim IA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():63-70. PubMed ID: 27322631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.